I would pause these a couple months ahead of trying for a baby, much like other treatments when you can, since we still lack proof they are harmless. This marks the early stage of learning whether they pose risks, yet confirmation may take ages because review boards refuse to greenlight any formal study. Data will instead accumulate from unplanned uses spanning many years. Nothing concerning has shown up so far, and similar findings point to first-trimester exposure probably being fine. Even so, conceiving while on them calls for input from a specialist, and doctors will avoid endorsing continued use in pregnancy until stronger evidence arrives. With all the births already linked to these drugs, early safety details could emerge sooner than expected.
I found this analysis that looked into issues with pregnancies. It explores how taking these receptor agonists while expecting affects results for the mother and baby versus other diabetes treatments. The main result showed better outcomes for the mom along with fewer early births and no big rise in birth defects or other problems for the child.